GlassScriptPhysician profile
Larry R Davis
NPI 1386628998
$1,829.61
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $321 · 2021: $617.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $283.25 | 2019-2021 | |
| Viiv Healthcare Company | $267.69 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $205.06 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $175.05 | 2020-2021 | |
| Vifor Pharma, INC. | $134.17 | 2019-2021 | |
| Veloxis Pharmaceuticals, INC. | $132.22 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $123.32 | 2021 | |
| Mallinckrodt Enterprises LLC | $105.40 | 2019 | |
| Horizon Therapeutics Plc | $92.70 | 2020-2021 | |
| Allergan, INC. | $54.35 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $54.23 | 2019 | |
| Alexion Pharmaceuticals, INC. | $46.24 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.45 | 2021 | |
| Aurinia Pharma U.S., INC. | $27.63 | 2021 | |
| Daiichi Sankyo INC. | $22.80 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.28 | 2021 | |
| Amicus Therapeutics, INC. | $19.13 | 2021 | |
| Leadiant Biosciences, INC. | $18.40 | 2019 | |
| Novo Nordisk INC | $17.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.